Abdominal mesotherapy injection extended the absorption of follicle-stimulating hormone

Fertility and Sterility

Volumn 95, Issue 6, 2011, Pages

  Hsu, Chao Chin ^a,b   Kuo, Hsin Chih ^b   Hsu, Chao Tien ^b   Gu, Qing ^c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

FSH; hypodermic injection; mesotherapy; pharmacokinetics

Indexed keywords

RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ADMINISTRATION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; MESOTHERAPY; NORMAL HUMAN; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; SINGLE DRUG DOSE;

EID: 79954995838     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.12.007     Document Type: Article

References (21)

1. G.S. Jones, A.A. Acosta, J.E. Garcia, R.E. Bernardus, and Z. Rosenwaks The effect of follicle-stimulating hormone without additional luteinizing hormone on follicular stimulation and oocyte development in normal ovulatory women Fertil Steril 43 1985 696 702 (Pubitemid 15062546)
2. B.C.J.M. Fauser, and A.M. van Heusden Manipulation of human ovarian function: physiological concepts and clinical consequences Endocr Rev 18 1997 71 106 (Pubitemid 27076456)
3. J.-Y. le Cotonnec, H.C. Porchet, V. Beltrami, A. Khan, S. Toon, and M. Rowland Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH Fertil Steril 61 1994 669 678 (Pubitemid 24114359)
4. C. Weenen, J.E. Pena, S.V. Pollak, J. Klein, L. Lobel, and R.K. Trousdale Long-acting follicle-stimulating hormone analogs containing N-linked glycosylation exhibited increased bioactivity compared with O-linked analogs in female rats J Clin Endoc Metab 89 2004 5204 5212 (Pubitemid 39391470)
5. B.C.J.M. Fauser, B.M.J.L. Mannaerts, P. Devroey, A. Leader, I. Boime, and D.T. Baird Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency Hum Reprod Update 15 2009 309 321
6. C.C. Hsu, C.T. Hsu, Q. Gu, and S.T. Wang Intermittent vaginal injections of gonadotrophins for ovarian stimulation in IVF treatment Reprod Biomed Online 16 2008 617 620 (Pubitemid 351721729)
7. M. Pistor Un defi therapeutique: la mesotherapie 3rd ed. 1979 Malonie Paris
8. C. Bulletti, D. de Ziegler, C. Flamigni, E. Giacomucci, V. Polli, and G. Bolelli Targeted drug delivery in gynecology: the first uterine pass effect Hum Reprod 12 1997 1073 1079 (Pubitemid 27271774)
9. E. Cicinelli, and de Ziegler Transvaginal progesterone: evidence for a new functional "portal system" flowing from the vagina to the uterus Hum Reprod Update 5 1999 365 372 (Pubitemid 29381282)
10. C.C. Hsu, H.C. Kuo, C.T. Hsu, and Q. Gu The absorption and uptake of recombinant human follicle-stimulating hormone through vaginal subcutaneous injections - a pharmacokinetic study Reprod Biol Endocrinol 7 2009 107 118
11. R.A. Thierree, and D. Mrejen Microcirculation, mesotherapy and thermography J Mal Vasc 10 Suppl A 1985 207 208 (Pubitemid 15027957)
12. A. Kaplan, and Raincourt Devenir d'un produit marque injecté par quatre voies differentes Bull Soc Fr Mesother 1985 62
13. J. Le Coz Traite de mesotherapie 2004 Masson Paris
14. H.C. Porchet, and J.-Y. le Cotonnec Pharmacokinetic and pharmacodynamic characteristic of recombinant human follicle-stimulating hormone Assist Reprod Rev 4 1994 110 117 (Pubitemid 24292716)
15. M.J.L. Mannaerts, F. Rombout, H.J. Out, and H.C. Bennink Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy Hum Reprod Update 2 1996 153 161 (Pubitemid 26173041)
16. S.C. Low, S.L. Nunes, A.J. Bitonti, and J.A. Dumont Oral and pulmonary delivery of FSH-Fc fusion proteins via neonatal Fc receptor-mediated transcytosis Hum Reprod 20 2005 1805 1813 (Pubitemid 40932360)
17. J.A. Dumont, A.J. Bitonti, D. Clark, S. Evans, M. Pickford, and S.P. Newman Delivery of an erythropoietin-Fc fusion protein by inhalation in humans through an immunoglobulin transport pathway J Aerosol Med 18 2005 294 303 (Pubitemid 41395731)
18. D. Navot, P.A. Bergh, and R. Palermo Pathophysiology and clinical management of ovarian hyperstimulation M. Filicori, C. Flamigni, Ovulation induction: basic and clinical advances 1994 Elsevier Amsterdam 319 329
19. D.M. Dudzinski, and A.S. Kesselheim Scientific and legal viability of follow-on protein drugs N Engl J Med 358 2008 843 849
20. S. Louët Lessons from Eprex for biogeneric firms Nat Biotechnol 21 2003 956 957
21. J.K. Aronson Meyler's side effects of endocrine and metabolic drugs 2009 Elsevier Amsterdam